{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:33:22Z","timestamp":1783103602500,"version":"3.54.6"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.modpat.2026.100980","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:17:49Z","timestamp":1771658269000},"page":"100980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Loss of Methylthioadenosine Phosphorylase (MTAP) Expression: A Potentially Useful Tool for Distinguishing Sarcomatoid Urothelial Carcinoma From Inflammatory Myofibroblastic Tumor"],"prefix":"10.1016","volume":"39","author":[{"given":"Huili","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Argani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Pallavajjala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S.","family":"Baras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara L.","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Matoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6932-8985","authenticated-orcid":false,"given":"Ezra G.","family":"Baraban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.modpat.2026.100980_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00345-025-05540-5","article-title":"A histopathological snapshot of bladder cancer: a Johannesburg experience of 1480 histopathology reports","volume":"43","author":"Jonosky","year":"2025","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.modpat.2026.100980_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10408363.2025.2464248","article-title":"Diagnostic workout of glandular malignant lesions of the bladder according to the 5th WHO classification","volume":"62","author":"Sanguedolce","year":"2025","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"5","key":"10.1016\/j.modpat.2026.100980_bib3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/his.15287","article-title":"Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature","volume":"85","author":"Lobo","year":"2024","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.modpat.2026.100980_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/biomedicines13010086","article-title":"Advances in therapy for urothelial and non-urothelial subtype histologies of advanced bladder cancer: from etiology to current development","volume":"13","author":"Kwon","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.modpat.2026.100980_bib5","article-title":"Clinical efficacy analysis of partial cystectomy and radical cystectomy in the treatment of muscle-invasive sarcomatoid carcinoma of the urinary bladder","volume":"14","author":"Xiao","year":"2024","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.modpat.2026.100980_bib6","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.juro.2007.08.038","article-title":"Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder","volume":"178","author":"Wright","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.modpat.2026.100980_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/454792","article-title":"Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases","volume":"2010","author":"Wang","year":"2010","journal-title":"Sarcoma"},{"issue":"12","key":"10.1016\/j.modpat.2026.100980_bib8","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/01.pas.0000213280.35413.1b","article-title":"Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma","volume":"30","author":"Montgomery","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.100980_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jcp.2007.049387","article-title":"Inflammatory myofibroblastic tumours: where are we now?","volume":"61","author":"Gleason","year":"2008","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.100980_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00000478-200106000-00007","article-title":"Anaplastic lymphoma kinase expression in inflammatory pseudotumors","volume":"25","author":"Chan","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"15","key":"10.1016\/j.modpat.2026.100980_bib11","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.3390\/cancers14153662","article-title":"Inflammatory myofibroblastic tumour: state of the art","volume":"14","author":"Gros","year":"2022","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.modpat.2026.100980_bib12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/2159-8290.CD-14-0377","article-title":"Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions","volume":"4","author":"Lovly","year":"2014","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.modpat.2026.100980_bib13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jjco\/hyad074","article-title":"Inflammatory myofibroblastic tumors: recent progress and future of targeted therapy","volume":"53","author":"Nakano","year":"2023","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"10.1016\/j.modpat.2026.100980_bib14","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/diagnostics12061450","article-title":"NTRK fusions in 1113 solid tumors in a single institution","volume":"12","author":"Bang","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"22","key":"10.1016\/j.modpat.2026.100980_bib15","first-page":"6639","article-title":"Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a\/ARF), acts as a tumor suppressor in a breast cancer cell line","volume":"62","author":"Christopher","year":"2002","journal-title":"Cancer Res"},{"issue":"26","key":"10.1016\/j.modpat.2026.100980_bib16","doi-asserted-by":"crossref","first-page":"12324","DOI":"10.1016\/S0021-9258(18)67242-4","article-title":"Purification and characterization of 5\u2019-deoxy-5\u2019-methylthioadenosine phosphorylase from human placenta","volume":"261","author":"Della Ragione","year":"1986","journal-title":"J Biol Chem"},{"issue":"50","key":"10.1016\/j.modpat.2026.100980_bib17","doi-asserted-by":"crossref","first-page":"49868","DOI":"10.1074\/jbc.M308451200","article-title":"Methylthioadenosine phosphorylase regulates ornithine decarboxylase by production of downstream metabolites","volume":"278","author":"Subhi","year":"2003","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.modpat.2026.100980_bib18","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/PAS.0000000000002297","article-title":"Prevalence of S-methyl-5\u2019-thioadenosine phosphorylase (MTAP) deficiency in human cancer: a tissue microarray study on 13,067 tumors from 149 different tumor types","volume":"48","author":"Gorbokon","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.100980_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13000-023-01416-7","article-title":"Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma","volume":"18","author":"Yoshida","year":"2023","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.modpat.2026.100980_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.18632\/oncotarget.28376","article-title":"Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss","volume":"14","author":"Bou Zerdan","year":"2023","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.modpat.2026.100980_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/DAD.0000000000002726","article-title":"Loss of p16 immunoexpression and deletions of CDKN2A in the progression of extramammary Paget disease: an immunohistochemical and genetic study of 24 invasive\/metastatic cases","volume":"46","author":"Hiraki","year":"2024","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.100980_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/jcp-2023-209341","article-title":"Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers","volume":"78","author":"Mauri","year":"2025","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.100980_bib23","article-title":"Hemizygous deletion of cyclin-dependent kinase inhibitor 2A\/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma","volume":"6","author":"Otsuji","year":"2024","journal-title":"Neurooncol Adv"},{"issue":"2","key":"10.1016\/j.modpat.2026.100980_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11060-024-04661-y","article-title":"Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of 11C-methionine in IDH-mutant astrocytoma","volume":"168","author":"Yamamura","year":"2024","journal-title":"J Neurooncol"},{"issue":"19","key":"10.1016\/j.modpat.2026.100980_bib25","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.3390\/cancers16193299","article-title":"MTAP and p16 IHC as markers for CDKN2A\/B loss in meningiomas","volume":"16","author":"Ozkizilkaya","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.modpat.2026.100980_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151582","article-title":"Evaluation of MTAP immunohistochemistry loss of expression in ovarian serous borderline tumors as a potential marker for prognosis and progression","volume":"48","author":"Nilforoushan","year":"2020","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.100980_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/2056-4538.70012","article-title":"Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer","volume":"11","author":"Gorbokon","year":"2025","journal-title":"J Pathol Clin Res"},{"issue":"9","key":"10.1016\/j.modpat.2026.100980_bib28","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.jid.2020.01.024","article-title":"Loss of both CDKN2A and CDKN2B allows for centrosome overduplication in melanoma","volume":"140","author":"Patel","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"7283","key":"10.1016\/j.modpat.2026.100980_bib29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.modpat.2026.100980_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.it.2022.03.003","article-title":"All is not lost: learning from 9p21 loss in cancer","volume":"43","author":"Spiliopoulou","year":"2022","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.modpat.2026.100980_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0165-4608(95)00157-3","article-title":"Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines","volume":"86","author":"Zhang","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.modpat.2026.100980_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107963","article-title":"MTAP as an emerging biomarker in thoracic malignancies","volume":"197","author":"Brune","year":"2024","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2026.100980_bib33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/his.15324","article-title":"MTAP protein status is highly concordant with CDKN2A fluorescent in situ hybridization and allows stratification of the luminal subtype in muscle-invasive bladder cancer","volume":"86","author":"Olkhov-Mitsel","year":"2025","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.modpat.2026.100980_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100495","article-title":"Loss of MTAP expression by immunohistochemistry is a surrogate marker for homozygous 9p21.3 deletion in urothelial carcinoma","volume":"37","author":"Vlajnic","year":"2024","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.100980_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100420","article-title":"Comparison of immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization for detection of MTAP loss in pleural mesothelioma","volume":"37","author":"Febres-Aldana","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.100980_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2022.152004","article-title":"Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma\/sarcomatoid pleural mesothelioma with desmoplastic features","volume":"60","author":"Sa-Ngiamwibool","year":"2022","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.modpat.2026.100980_bib37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.lungcan.2018.09.019","article-title":"A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis","volume":"125","author":"Kinoshita","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.modpat.2026.100980_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.humpath.2021.04.001","article-title":"Molecular pathology of urothelial carcinoma","volume":"113","author":"Lopez-Beltran","year":"2021","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.100980_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100472","article-title":"High-grade, nonsarcomatoid chromophobe renal cell carcinoma: a series of 22 cases with novel molecular features on a subset","volume":"37","author":"Baraban","year":"2024","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.100980_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100684","article-title":"Diagnostic and prognostic\/therapeutic significance of comprehensive analysis of bone and soft tissue tumors using optical genome mapping and next-generation sequencing","volume":"38","author":"Ghabrial","year":"2025","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.100980_bib41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41391-018-0093-2","article-title":"PTEN status assessment in the Johns Hopkins active surveillance cohort","volume":"22","author":"Tosoian","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.modpat.2026.100980_bib42","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/PAS.0b013e3182159dec","article-title":"Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation","volume":"35","author":"Cheng","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2026.100980_bib43","article-title":"Ensartinib for EML4-ALK-positive lung adenocarcinoma with comorbid mutations in TP53, EGFR, and ERBB2: a case report","volume":"15","author":"Huang","year":"2025","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.100980_bib44","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/s41467-025-57309-4","article-title":"Comprehensive characterization of early-onset lung cancer, in Chinese young adults","volume":"16","author":"Tian","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.modpat.2026.100980_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.12703\/r\/12-21","article-title":"ALK-positive anaplastic large cell lymphoma in adults","volume":"12","author":"Gromowsky","year":"2023","journal-title":"Fac Rev"},{"issue":"7","key":"10.1016\/j.modpat.2026.100980_bib46","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0000000000001476","article-title":"Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers: III: molecular pathology of kidney cancer","volume":"44","author":"Williamson","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2026.100980_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103325","article-title":"Identification of ALK gene alterations in urothelial carcinoma","volume":"9","author":"Bellmunt","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.modpat.2026.100980_bib48","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/PAS.0000000000000240","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2026.100980_bib49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/PAS.0000000000002220","article-title":"Uterine inflammatory myofibroblastic tumors: p16 as a surrogate for CDKN2A deletion and predictor of aggressive behavior","volume":"48","author":"Devins","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.100980_bib50","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.2129","article-title":"Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation","volume":"211","author":"Sung","year":"2007","journal-title":"J Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2026.100980_bib51","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/arpa.2023-0304-RA","article-title":"Guidelines for pathologic diagnosis of mesothelioma: 2023 update of the consensus statement from the International Mesothelioma Interest Group","volume":"148","author":"Husain","year":"2024","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1016\/j.modpat.2026.100980_bib52","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s41379-022-01081-z","article-title":"Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma","volume":"35","author":"Chapel","year":"2022","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.100980_bib53","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/ajcp\/90.2.216","article-title":"Transitional cell carcinoma of the urinary bladder with pseudosarcomatous stroma","volume":"90","author":"Young","year":"1988","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2026.100980_bib54","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/00000478-198909000-00008","article-title":"Pseudosarcomatous stromal reaction in primary and metastatic urothelial carcinoma. A source of diagnostic difficulty","volume":"13","author":"Mahadevia","year":"1989","journal-title":"Am J Surg Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:35:00Z","timestamp":1782128100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0893395226000232"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.100980","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of Methylthioadenosine Phosphorylase (MTAP) Expression: A Potentially Useful Tool for Distinguishing Sarcomatoid Urothelial Carcinoma From Inflammatory Myofibroblastic Tumor","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.100980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100980"}}